---
title: Is neoadjuvant chemotherapy followed by surgery the appropriate treatment for
  esophagogastric signet ring cell carcinomas? A systematic review and meta-analysis
date: '2024-05-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38770165/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240521183404&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: The current meta-analysis could not demonstrate beneficial
  effects of nCTX for SRCC patients. Histopathological response to and survival benefits
  of non-taxane-based nCTX seem to be lower in comparison to non-SRC esophagogastric
  cancer. However, certainty of evidence is low due to the scarcity of high-quality
  trials. Further research is necessary to determine optimal treatment for SRCC ...'
disable_comments: true
---
CONCLUSION: The current meta-analysis could not demonstrate beneficial effects of nCTX for SRCC patients. Histopathological response to and survival benefits of non-taxane-based nCTX seem to be lower in comparison to non-SRC esophagogastric cancer. However, certainty of evidence is low due to the scarcity of high-quality trials. Further research is necessary to determine optimal treatment for SRCC ...